Beiersdorf is a finished-dose manufacturer based in Germany. It appears in 76 regulatory filings across 11 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada, DIGEMAPS (DO) and EMA. Its GMP standing is certified by ZLG (DE), BPOM (ID) and EMA. Its most recent recorded inspection, by US FDA, closed on 9 December 2021 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Hamburg, Germany | Not on file |
| Germany, Germany | 3002806448 |
| INDEPENDENCIA, Peru | Not on file |
| Terrugem, Portugal | Not on file |
| CABANILLAS DEL CAMPO, Portugal | Not on file |
| Stamford, United States | 3010063830 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| Health Canada | 32 | None |
| DIGEMAPS (DO) | 14 | None |
| EMA | 10 | 2 |
| ISP (CL) | 6 | None |
| EEC_EAEU | 5 | None |
| MPA (SE) | 2 | None |
| ZLG (DE) | None | 4 |
| BPOM (ID) | None | 4 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | $260.0B | Not reported | Not reported |
| 2023 | $230.0B | Not reported | Not reported |
| 2022 | $190.0B | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Beiersdorf comes back tiered against every other supplier able to file there.
Start for free